Researchers have designed a new, more powerful mRNA that enhanced immune responses to the SARS-CoV-2 mRNA vaccine when used as an adjuvant. In this lymph node, the researchers observed increased B-cell activity in germinal centers (hotspots of antibody production) and...
CHENGDU, China, Aug. 8, 2024 /PRNewswire/ — WestGene Biopharma is proud to announce that its mRNA therapeutic cancer vaccine, WGc-043, has received dual IND approvals from China’s National Medical Products Administration (NMPA) and the US FDA. This...
Besides vaccines, mRNA technology is being explored for therapeutic applications in oncology, infectious diseases, genetic disorders, and other areas. This diversification expands the market potential. The mRNA vaccines and therapeutics market was projected to attain...
Huntingtin. Crystallographic structure of the N-terminal region of the human Huntingtin protein with an artificially attached Maltose-Binding protein used for crystallographic purposes. Credit: Public domain In Huntington’s disease, the mutant huntingtin gene...
On July 8th, Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation (MTPC) officially entered into a joint agreement to co-promote Moderna’s mRNA respiratory vaccine portfolio in Japan, alongside Moderna’s COVID-19 vaccine, Spikevax. Moderna’s Success Sparks...